Human autoantibodies underlying infectious diseases

A Puel, P Bastard, J Bustamante… - Journal of Experimental …, 2022 - rupress.org
The vast interindividual clinical variability observed in any microbial infection—ranging from
silent infection to lethal disease—is increasingly being explained by human genetic and …

Silica‐related diseases in the modern world

RF Hoy, DC Chambers - Allergy, 2020 - Wiley Online Library
Silicosis is an ancient and potentially fatal pneumoconiosis caused by exposure to
respirable crystalline silica. Silicosis is historically a disease of miners; however, failure to …

Systemic juvenile idiopathic arthritis–associated lung disease: characterization and risk factors

GS Schulert, S Yasin, B Carey, C Chalk… - Arthritis & …, 2019 - Wiley Online Library
Objective Systemic juvenile idiopathic arthritis (JIA) is associated with a recently recognized,
albeit poorly defined and characterized, lung disease (LD). The objective of this study was to …

Alveolar lipids in pulmonary disease. A review

CW Agudelo, G Samaha, I Garcia-Arcos - Lipids in health and disease, 2020 - Springer
Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is
composed by multiple cell types with specialized functions and coordinately acting to meet …

Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection

C Schneider, SP Nobs, AK Heer, M Kurrer… - PLoS …, 2014 - journals.plos.org
Alveolar macrophages (AM) are critical for defense against bacterial and fungal infections.
However, a definitive role of AM in viral infections remains unclear. We here report that AM …

Pulmonary macrophage transplantation therapy

T Suzuki, P Arumugam, T Sakagami, N Lachmann… - Nature, 2014 - nature.com
Bone-marrow transplantation is an effective cell therapy but requires myeloablation, which
increases infection risk and mortality. Recent lineage-tracing studies documenting that …

Pulmonary alveolar proteinosis

BC Trapnell, JA Whitsett, K Nakata - New England Journal of …, 2003 - Mass Medical Soc
In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the alveoli
because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …

Emergent high fatality lung disease in systemic juvenile arthritis

VE Saper, G Chen, GH Deutsch… - Annals of the …, 2019 - ard.bmj.com
Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In …

Pivotal roles of GM‐CSF in autoimmunity and inflammation

A Shiomi, T Usui - Mediators of inflammation, 2015 - Wiley Online Library
Granulocyte macrophage‐colony stimulating factor (GM‐CSF) is a hematopoietic growth
factor, which stimulates the proliferation of granulocytes and macrophages from bone …

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan

Y Inoue, BC Trapnell, R Tazawa, T Arai… - American journal of …, 2008 - atsjournals.org
Rationale: Acquired pulmonary alveolar proteinosis (PAP) is a syndrome characterized by
pulmonary surfactant accumulation occurring in association with granulocyte/macrophage …